Macrogenics (MGNX) Tops Q3 EPS by 38c

Macrogenics (NASDAQ: MGNX) reported Q3 EPS of $0.28, $0.38 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $10.39 million versus the consensus estimate of $49.24 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight